Literature DB >> 21971048

The RNA-binding protein HuR opposes the repression of ERBB-2 gene expression by microRNA miR-331-3p in prostate cancer cells.

Michael R Epis1, Andrew Barker, Keith M Giles, Dianne J Beveridge, Peter J Leedman.   

Abstract

ERBB-2 overexpression is associated with the development and progression of cancer and mediates its resistance to therapy. It has been suggested that post-transcriptional mechanisms control the overexpression of ERBB-2 in prostate cancer (PCa). We recently demonstrated that the 3'-untranslated region (3'-UTR) of ERBB-2 mRNA contains two specific target sites for binding of the microRNA miR-331-3p and that miR-331-3p represses ERBB-2 expression and signaling in PCa cells. Here we investigate a U-rich element situated in close proximity to the distal miR-331-3p target site in the ERBB-2 3'-UTR. Specific binding of HuR to this U-rich element promotes ERBB-2 expression in PCa cells. We show that HuR antagonizes the repressive action of miR-331-3p on its distal ERBB-2 3'-UTR target site. These results support a model in which the interplay between RNA-binding proteins and microRNAs controls the post-transcriptional regulation of gene expression and suggest that both HuR and miR-331-3p participate in the overexpression of ERBB-2 observed in some PCas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21971048      PMCID: PMC3308856          DOI: 10.1074/jbc.M111.301481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Gene expression studies in prostate cancer tissue: which reference gene should be selected for normalization?

Authors:  Falk Ohl; Monika Jung; Chuanliang Xu; Carsten Stephan; Anja Rabien; Mick Burkhardt; Andreas Nitsche; Glen Kristiansen; Stefan A Loening; Aleksandar Radonić; Klaus Jung
Journal:  J Mol Med (Berl)       Date:  2005-10-07       Impact factor: 4.599

3.  A dead end for microRNAs.

Authors:  René F Ketting
Journal:  Cell       Date:  2007-12-28       Impact factor: 41.582

4.  The 3'-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein.

Authors:  Keith M Giles; John M Daly; Dianne J Beveridge; Andrew M Thomson; Dominic C Voon; Henry M Furneaux; Jalal A Jazayeri; Peter J Leedman
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

5.  Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer.

Authors:  Sarah Minner; Birte Jessen; Lars Stiedenroth; Eike Burandt; Jens Köllermann; Martina Mirlacher; Andreas Erbersdobler; Christian Eichelberg; Margit Fisch; Tim Henrik Brümmendorf; Carsten Bokemeyer; Ronald Simon; Thomas Steuber; Markus Graefen; Hartwig Huland; Guido Sauter; Thorsten Schlomm
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

6.  miR-519 suppresses tumor growth by reducing HuR levels.

Authors:  Kotb Abdelmohsen; Mihee M Kim; Subramanya Srikantan; Evi M Mercken; Sarah E Brennan; Gerald M Wilson; Rafael de Cabo; Myriam Gorospe
Journal:  Cell Cycle       Date:  2010-04-01       Impact factor: 4.534

7.  Widespread deregulation of microRNA expression in human prostate cancer.

Authors:  M Ozen; C J Creighton; M Ozdemir; M Ittmann
Journal:  Oncogene       Date:  2007-09-24       Impact factor: 9.867

8.  miR-331-3p regulates ERBB-2 expression and androgen receptor signaling in prostate cancer.

Authors:  Michael R Epis; Keith M Giles; Andrew Barker; Tulene S Kendrick; Peter J Leedman
Journal:  J Biol Chem       Date:  2009-07-07       Impact factor: 5.157

9.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  53 in total

1.  Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells.

Authors:  Sheng Tan; Keshuo Ding; Qing-Yun Chong; Junsong Zhao; Yuan Liu; Yunying Shao; Yuanyuan Zhang; Qing Yu; Zirui Xiong; Weijie Zhang; Min Zhang; Gaopeng Li; Xiaoni Li; Xiangjun Kong; Akhlaq Ahmad; Zhengsheng Wu; Qiang Wu; Xiaodong Zhao; Peter E Lobie; Tao Zhu
Journal:  J Biol Chem       Date:  2017-06-21       Impact factor: 5.157

2.  Regulation of context-specific gene expression by posttranscriptional switches.

Authors:  Gopinath M Sundaram; Prabha Sampath
Journal:  Transcription       Date:  2013 Sep-Dec

Review 3.  Involvement of microRNAs in HER2 signaling and trastuzumab treatment.

Authors:  Ling Mao; Ai-Jun Sun; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-10-12

4.  ErbB-2 signaling in advanced prostate cancer progression and potential therapy

Authors:  Dannah R Miller; Matthew A Ingersoll; Ming-Fong Lin
Journal:  Endocr Relat Cancer       Date:  2019-04-01       Impact factor: 5.678

5.  Posttranscriptional Regulation of the Inflammatory Marker C-Reactive Protein by the RNA-Binding Protein HuR and MicroRNA 637.

Authors:  Yoonseo Kim; Nicole Noren Hooten; Douglas F Dluzen; Jennifer L Martindale; Myriam Gorospe; Michele K Evans
Journal:  Mol Cell Biol       Date:  2015-10-05       Impact factor: 4.272

Review 6.  Post-transcriptional control of gene expression by AUF1: mechanisms, physiological targets, and regulation.

Authors:  Elizabeth J F White; Gary Brewer; Gerald M Wilson
Journal:  Biochim Biophys Acta       Date:  2012-12-14

7.  Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.

Authors:  Michael R Epis; Keith M Giles; Felicity C Kalinowski; Andrew Barker; Ronald J Cohen; Peter J Leedman
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

Review 8.  Mechanisms coordinating ELAV/Hu mRNA regulons.

Authors:  Laura E Simone; Jack D Keene
Journal:  Curr Opin Genet Dev       Date:  2013-01-09       Impact factor: 5.578

Review 9.  The multilayered complexity of ceRNA crosstalk and competition.

Authors:  Yvonne Tay; John Rinn; Pier Paolo Pandolfi
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

10.  Dephosphorylation of HuR protein during alphavirus infection is associated with HuR relocalization to the cytoplasm.

Authors:  Alexa M Dickson; John R Anderson; Michael D Barnhart; Kevin J Sokoloski; Lauren Oko; Mateusz Opyrchal; Evanthia Galanis; Carol J Wilusz; Thomas E Morrison; Jeffrey Wilusz
Journal:  J Biol Chem       Date:  2012-08-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.